We are live on
!
Find out more
Alyeska Investment Group Portfolio holdings
AUM
$35.4B
1-Year Est. Return
33.54%
This Fund
S&P 500
This Quarter
Est. Return
+3.53%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.33%
AUM
$12B
AUM Growth
-$353M
(-2.9%)
Cap. Flow
-$617M
Cap. Flow
% of AUM
-5.16%
Top 10 Holdings %
Top 10 Hldgs %
12.46%
Holding
637
New
171
Increased
105
Reduced
150
Closed
191
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Delta Air Lines
DAL
|
+$140M |
| 2 |
AbbVie
ABBV
|
+$119M |
| 3 |
KeyCorp
KEY
|
+$115M |
| 4 |
F5
FFIV
|
+$111M |
| 5 |
Walmart Inc
WMT
|
+$110M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Oracle
ORCL
|
+$146M |
| 2 |
S&P Global
SPGI
|
+$142M |
| 3 |
Eli Lilly
LLY
|
+$133M |
| 4 |
Labcorp
LH
|
+$131M |
| 5 |
RHT
Red Hat Inc
RHT
|
+$121M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.86% |
| 2 | Healthcare | 13.19% |
| 3 | Industrials | 12.91% |
| 4 | Consumer Discretionary | 10.27% |
| 5 | Financials | 9.49% |
Similar funds
SAM
VIA
Alyeska Investment Group's Q2 2017 Portfolio in Review
As of Q2 2017, Alyeska Investment Group held 637 positions worth $12B, down 2.9% from $12.3B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Alyeska Investment Group withdrew a net $617M in Q2 2017, closing 191 positions and reducing 150 holdings. Its most notable exit was Eli Lilly, an estimated $133M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 14% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Alyeska Investment Group opened a new position in AbbVie worth $128M.
- Alyeska Investment Group's largest Q2 2017 buy was AbbVie: 1,771,895 shares worth $128M.
- Alyeska Investment Group added most to Delta Air Lines in Q2 2017, an estimated $140M increase.
- Alyeska Investment Group's biggest Q2 2017 reduction was Oracle, cutting an estimated $146M.
- Alyeska Investment Group fully exited Eli Lilly in Q2 2017, selling an estimated $133M.
- Alyeska Investment Group's ten largest holdings make up 12% of its $12B portfolio in Q2 2017.
- Alyeska Investment Group opened 171 new positions and closed 191 in Q2 2017.
- Alyeska Investment Group's portfolio value fell 2.9% quarter-over-quarter to $12B.
Based on Alyeska Investment Group's 13F filing for Q2 2017, filed 14 Aug 2017.